ROB'E

It is always an incredible opportunity to bring clinicians and engineers together for focused collaboration. We were privileged to have Dr. Mark Webster, Gorav Ailawadi, MD, MBA, Charanjit (Chet) Rihal, and Santiago Garcia join us in Santa Cruz this past month. Thanks for your time, energy, and input...your enthusiasm was shared by all!

Sentante's Robotic Revolution: Successful Human Trial Completed! 🎉 The Sentante Endovascular Robotic System has hit a major milestone, completing its first in human clinical study led by Dainis Krievins, MD, PhD in Riga, Latvia. Over three weeks, 10 patients underwent 21 fully robotic procedures! Sentante's fully robotic, remote-operated system shields medical teams from radiation while ensuring precision with haptic feedback. This breakthrough promises to transform endovascular treatment, enhancing safety for patients and healthcare providers. Get ready for Sentante's global launch next year! 🌎🚀

Blending #advanced imaging, #AR/VR, and #robotics to revolutionize endovascular procedures and ergonomics may be the future of IR. We might unlock new standards of precision and efficiency —all for the direct benefit of more patients, not in the metaverse. And for once, it could be as intuitive as a video game! Memorial Sloan Kettering Cancer Center

Blending #advanced imaging, #AR/VR, and #robotics to revolutionize endovascular procedures and ergonomics may be the future of IR. We might unlock new standards of precision and efficiency —all for the direct benefit of more patients, not in the metaverse. And for once, it could be as intuitive as a video game! Memorial Sloan Kettering Cancer Center

Wow, SS Innovations continues to create buzz around its Mantra 3 #surgicalrobotic System. I had the opportunity to get a tour from COO and President Vishwa Pascual Srivastava, MD at this year's #SRS2024. Check out the video in the comments below. #robotics #surgery #roboticsurgery #medtech #medicaldevices ADD: As you'll learn from the video the pace of #innovation of the Mantra systems has been astounding. Check it out!

I am super excited - you could say "Stoked" in old parlance. I think we are moving beyond the realms of rigid multi arm robots and we are barreling down the bronchus with flexible robots. https://lnkd.in/dt7PTCBi Endolumenal flexible robotics has just started but the future is bright and for me it is an exciting next step on the journey for many of the companies out there. It still gets less press than say a daVinci 5 - but it could be way cooler in the coming years. (I'm bigging you up flexible endo robotics teams). Check out ION from Intuitive #intuitive Monarch from Johnson & Johnson MedTech #Ethicon and Galaxy from Noah Medical as well as a guest appearance by MicroPort MedBot and their transbronchial robotic system #endolumenal #endoscopy #bronchoscopy #flexiblerobotics #rendezvous #surgicalrobotics #nextgeneration #innovation

While 75% of cardiology leaders say staff shortages are negatively impacting patient care, AI has the potential to help. These are the findings in the Future Health 2024 global report and echoed among attendees at the world's largest cardiovascular congress. At #ESCCongress, cardiologists got a firsthand look at the latest medical imaging and AI-enabled innovations. Here are three ways AI can help deliver better cardiac care to more people. 1️⃣ AI helps improve heart scans The global increase in cardiovascular disease, stroke, and dementia continues to put an unsustainable burden on healthcare systems worldwide. The pressure to improve efficiency in cardiology departments have never been higher. New AI-based capabilities from Philips are helping accelerate and automate echocardiography, an essential tool for diagnosing and treating heart disease. “Having seen what AI can do, cardiology leaders now seem to be more receptive to its use in clinical settings,” said Atul Gupta, MD, Chief Medical Officer of Diagnosis and Treatment at Philips. 2️⃣ AI helps address heart problems in cancer patients Did you know that one in ten cancer patients will survive their cancer, only to die of cardiovascular disease*? Teresa Lopez cardiologist and Co-Chair of Cardio-Oncology Guidelines at La Paz University Hospital in Madrid, explained how the latest Philips ultrasound innovation is tapping into AI to help doctors “quickly detect subtle warning signs [of cardiotoxicity].” When the earliest side effects of radiation and chemotherapy are detected, such as cardiotoxicity, “oncologists and hematologists can make appropriate clinical decisions” to improve patient outcomes. 3️⃣ AI extends access to cardiac care to more patients Traditionally it has been challenging for doctors performing complex cardiac procedures to navigate narrow spaces inside the heart valves in the smallest of patients. Now with our new, smaller probe, doctors can get high-quality cardiac images of everyone from 5kg babies to 90-year-old adults. And AI helps analyze the adult images captured by the probe. Pepe Zamorano, Professor at University Hospital Ramon y Cajal in Madrid commented: “AI really helps … you can analyze a wide variety of patients, that is real life.” Get more insights on how #cardiology leaders are tackling the rising tide of chronic heart disease: https://lnkd.in/dsAsu6Ty #FutureHealth #HealthcareInnovation European Society of Cardiology *Lopez Fernandez T, Lopez Sendon J. How to Improve Therapeutic Strategies to Reduce Cardiotoxicity. Anti-Cancer Treatments and Cardiotoxicity, Elsevier Inc. 2016.

Using cutting-edge AI and advanced robotics, this automated ultrasound device assesses cerebral blood flow velocity within the major conducting arteries and veins of the head and neck. It measures the occurrence of transient emboli signals within the bloodstream and helps identify brain illnesses and diseases that present as changes in cerebral blood flow. Do you know its name? #medtech #neurosurgery #robotics #artificialintelligence

We’re thrilled to announce that our groundbreaking work on #robotics in #echocardiography [ROB'E] has been published in the #StructuralHeart Journal! 🚀 This publication dives deep into the concept and design of our innovative technology that’s set to revolutionize #cardiacimaging. Stay tuned: #FIM data will be presented at #TCT2024 in Washington! 📅 💡🚀 Rebecca Hahn Marty Leon Juan Granada G. Burkhard Mackensen MD PhD FASE Stephen Little Dee Dee Wang, MD, FACC, FASE, FSCCT, FSCAI Moody Makar Julia Grapsa Marta Sitges Augustin Coisne Federico Asch Adnan Chhatriwalla David Skolnick Nadira Hamid Victoria Delgado Akhil Narang Partho Sengupta Linda Gillam, MD, MPH Marc-Angelo Bisotti thomas modine Ryan Madder Julien Niels Nijhof Firas Zahr Atul Gupta, MD Philip Rackliffe Dagfinn Saetre Kjetil Buer Olivier Gerard Omar Khalique, MD, FACC, FSCCT, FSCMR, FASE, FSCAI Cardiovascular Research Foundation Vipul Patel, M.D., F.A.C.S. Joe Mullings Giovanni Lauricella Dimitry Schewel, Priv.-Doz. Dr. med.

Central lines placement is one of the most common medical procedures in the world with over 20 million cases each year. What if robotics combined with integrated imaging could democratize this procedure by enabling fast & reliable vessel targeting? Led by Russell Seiber, OBVIUS Robotics, Inc. is an early-stage start-up based in South Florida that develops a hand-held, image-guided access system called CERTA for central venous catheterization (CVC) and vascular access. The company announced this week that the FDA has granted Breakthrough Device Designation for its robotic system. This designation expedites the review of innovative technologies. The CERTA Access System is a reusable hand-held imaging device that uses integrated ultrasound for targeting. The clinician single-handedly targets and accesses the vein with a push of a button for guidewire placement. A proprietary needle advancement design reduces the force required for access, which may reduce the number of attempts required. Last year, OBVIUS Robotics announced: 🔸 First-In-Human conducted in Paraguay (median time for access <3 min) 🔸 $10 Million Series A funding round #medtech #roboticsurgery #vascularaccess